pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

8,010 catalysts · 5,347 phase readout · 2,317 8k filing · 343 pdufa · 256 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 0 catalysts2026-07-31: 22 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,347
  • 8k filing2,317
  • pdufa343
  • earnings256
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›COMPLETEDphase readoutNCT07582107: Anatomical Landmark Method for Paediatric Port Catheter Tip Positioning

Sponsor: Ankara City Hospital Bilkent. Phase: . Conditions: Central Venous Catheterization, Vascular Access Devices, Pediatric Patients, Monitoring

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07552792: Impact of Hand Rub Placement on Patient Trust and Disease Stigma

Sponsor: Huashan Hospital. Phase: NA. Conditions: Noncommunicable Disease, Psoriasis

full page →ctgov ↗
›COMPLETEDphase readoutNCT07379034: The Effect of ShotBlocker and Vibration on Pain During Vaccination

Sponsor: Ataturk University. Phase: NA. Conditions: Vaccination, Pain, Infant, Shotblocker, Vibration

full page →ctgov ↗
›COMPLETEDphase readoutNCT02432534: Atorvastatin in Active Vitiligo

Sponsor: Centre Hospitalier Universitaire de Nice. Phase: PHASE2. Conditions: Vitiligo

full page →ctgov ↗
›RECRUITINGphase readoutNCT06017934: Promoting Increased Physical Activity in Hospitalised Older Adults

Sponsor: University of Southampton. Phase: NA. Conditions: Hospital-associated Deconditioning

full page →ctgov ↗
›RECRUITINGphase readoutNCT06332209: Randomized Trial of Tele Vs. Clinic TF-CBT in Puerto Rico

Sponsor: Medical University of South Carolina. Phase: NA. Conditions: Post-Traumatic Stress Disorder

full page →ctgov ↗
›COMPLETEDphase readoutNCT06632509: BD SiteRite(TM) 9 Ultrasound System - Clinical Study

Sponsor: Becton, Dickinson and Company. Phase: . Conditions: BD SiteRite 9 for VAD Insertion

full page →ctgov ↗
›COMPLETEDphase readoutNCT02007499: Pre-arrival Instructions Effect on Bystander Cardiopulmonary Resuscitation (CPR).

Sponsor: Medical College of Wisconsin. Phase: . Conditions: Heart Arrest, Cardiac Arrest, Cardiopulmonary Arrest, Out of Hospital Cardiac Arrest, Sudden Cardiac Death

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT01545999: Paired Associative Stimulation in the Dorsolateral Prefrontal Cortex in Patients With Schizophrenia

Sponsor: Centre for Addiction and Mental Health. Phase: NA. Conditions: Schizophrenia

full page →ctgov ↗
›RECRUITINGphase readoutNCT07105098: NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

Sponsor: Neurocrine Biosciences. Phase: PHASE3. Conditions: Schizophrenia

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07513363: The Role of Urinary RhoA, NGF, and BDNF Levels in Overactive Bladder and Vitamin D Deficiency

Sponsor: Tarik Emre Sener. Phase: NA. Conditions: Overactive Bladder, Vitamin D Deficiency

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT05777993: A Study to Provide Continued Access to Mitapivat for Participants Who Previously Completed an Agios-Sponsored Mitapivat Study

Sponsor: Agios Pharmaceuticals, Inc.. Phase: PHASE4. Conditions: Pyruvate Kinase Deficiency, Anemia, Hemolytic

full page →ctgov ↗
›SUSPENDEDphase readoutNCT06832293: My MS and My Menstrual Cycle

Sponsor: University of Alberta. Phase: . Conditions: Multiple Sclerosis, Menstrual Cycle

full page →ctgov ↗
›COMPLETEDphase readoutNCT06783621: A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of OnabotulinumtoxinA, JUVÉDERM® Products, KYBELLA, CoolSculpting Elite and SkinMedica Products

Sponsor: AbbVie. Phase: PHASE4. Conditions: Facial Contouring

full page →ctgov ↗
›COMPLETEDphase readoutNCT06044714: Effects of Acupuncture on Perceived Stress and Health in Military Service Members

Sponsor: United States Naval Medical Center, San Diego. Phase: NA. Conditions: Perceived Stress

full page →ctgov ↗
›RECRUITINGphase readoutNCT07505004: Double-blind, Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adults With Focal Seizures

Sponsor: Praxis Precision Medicines. Phase: PHASE3. Conditions: Focal Epilepsy

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT02636504: Evaluation of Three Pulp Vitality Tests

Sponsor: Columbia University. Phase: . Conditions: Dental Pulp Diseases, Dental Pulp Vitality Testing

full page →ctgov ↗
›RECRUITINGphase readoutNCT07459504: SMART Diets for MASLD

Sponsor: Michigan State University. Phase: PHASE2. Conditions: Metabolic-dysfunction Associated Steatotic Liver Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT01050504: Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer

Sponsor: University of Washington. Phase: . Conditions: Localized Renal Pelvis and Ureter Urothelial Carcinoma, Malignant Solid Neoplasm, Metastatic Malignant Neoplasm in the Bone, Metastatic Malignant Neoplasm in the Soft Tissues, Metastatic Renal Pelvis and Ureter Urothelial Carcinoma, Recurrent Bladder Carcinoma, Recurrent Prostate Carcinoma, Recurrent Renal Pelvis and Ureter Urothelial Carcinoma, Stage IV Bladder Cancer AJCC v7, Stage IV Bladder Urothelial Carcinoma AJCC v7, Stage IV Prostate Cancer AJCC v7

full page →ctgov ↗
›COMPLETEDphase readoutNCT04577404: Safety Extension Study of Oral Edaravone Administered in Subjects With Amyotrophic Lateral Sclerosis (ALS)

Sponsor: Tanabe Pharma America, Inc.. Phase: PHASE3. Conditions: Amyotrophic Lateral Sclerosis (ALS)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07336147: Dostarlimab, Cisplatin and Etoposide in Combination With Radiotherapy in Sandwich Sequence for Small Cell Neuroendocrine Cervical Carcinoma

Sponsor: Chang Gung Memorial Hospital. Phase: PHASE2. Conditions: Female

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07397247: Tonic Motor Activation (TOMAC) Therapy in Patients With Restless Legs Syndrome and Dopaminergic Augmentation

Sponsor: Noctrix Health, Inc.. Phase: NA. Conditions: Restless Legs Syndrome

full page →ctgov ↗
›RECRUITINGphase readoutNCT05030038: Oral Aromatase Inhibitors Modify the Gut Microbiome

Sponsor: Wake Forest University Health Sciences. Phase: . Conditions: Breast Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07357558: A Qualitative Study Investigating the Lived Experiences and Impact of Reproductive Issues in Adults With Primary Ciliary Dyskinesia

Sponsor: University Hospital Southampton NHS Foundation Trust. Phase: . Conditions: Primary Ciliary Dyskinesia (PCD)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05070858: A Study to Test How Safe Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Alone Are and How Well They Work in Adult Patients With Generalized Myasthenia Gravis

Sponsor: Regeneron Pharmaceuticals. Phase: PHASE3. Conditions: Generalized Myasthenia Gravis

full page →ctgov ↗
›COMPLETEDphase readoutNCT07145658: Multivitamin for Health and Cognition

Sponsor: Dr Anthony Hobson. Phase: NA. Conditions: Healthy, Cognition, Health

full page →ctgov ↗
›RECRUITINGphase readoutNCT06666348: Phase 1/2 Study of Mirdametinib + Vinblastine for Newly Diagnosed/Previously Untreated PLGG + Activation of MAPK

Sponsor: St. Justine's Hospital. Phase: PHASE1. Conditions: Pediatric Low-grade Glioma

full page →ctgov ↗
›RECRUITINGphase readoutNCT06471426: The Effect of Osteopathic Treatment on Craniocervico-Mandibular Dysfunction

Sponsor: Edward Via Virginia College of Osteopathic Medicine. Phase: NA. Conditions: Headache, Neck Pain

full page →ctgov ↗
›COMPLETEDphase readoutNCT03328026: Combination Study of SV-BR-1-GM With Retifanlimab

Sponsor: BriaCell Therapeutics Corporation. Phase: PHASE1. Conditions: Breast Cancer, Breast Neoplasm, Metastatic Breast Cancer, Breast Cancer Metastatic

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07593326: Midwife-Led Antenatal Perineal Massage Education in Primiparous Pregnant Women

Sponsor: Atlas University. Phase: NA. Conditions: Pregnancy, Fear of Childbirth, Antenatal Education

full page →ctgov ↗
›COMPLETEDphase readoutNCT03555578: Specified Drug-Use Survey of Leuprorelin Acetate Injection Kit 11.25 mg "All-Case Investigation: Spinal and Bulbar Muscular Atrophy (SBMA)"

Sponsor: Takeda. Phase: . Conditions: Spinal and Bulbar Muscular Atrophy

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05288985: Impact of Loco-regional Analgesia Following Placement of Erector Spinae Plane Catheter in Addition to Systemic Analgesia in Patients With Thoracic Trauma

Sponsor: Centre Hospitalier Departemental Vendee. Phase: NA. Conditions: Trauma Abdomen

full page →ctgov ↗
›COMPLETEDphase readoutNCT04250077: We The Village Family Support Study

Sponsor: We The Village, Inc.. Phase: NA. Conditions: Community Reinforcement And Family Training, Family Health, Substance-Related Disorders

full page →ctgov ↗
›RECRUITINGphase readoutNCT07444957: Safety and Effectiveness of the Crystalline Sirolimus-Eluting Device in Patients With Coronary Artery Disease

Sponsor: Fundación Interhospitalaria para la Investigación Cardiovascular FIC. Phase: . Conditions: Coronary Arterial Disease (CAD), NSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI), Stable Angina, Unstable Angina, NSTEMI, Drug Coated Balloon, ST-Elevation Myocardial Infarction, Silent Ischemia

full page →ctgov ↗
›RECRUITINGphase readoutNCT06605001: Development, Attention, and Inhibition Study

Sponsor: University of California, Davis. Phase: NA. Conditions: The Ability to Delay Gratification

full page →ctgov ↗
›RECRUITINGphase readoutNCT07278375: Target Trial Emulation for Pharmacologic Treatment of Neonatal Opioid Withdrawal Syndrome

Sponsor: HELP for NOWS Consortium. Phase: . Conditions: Neonatal Opioid Withdrawal Syndrome

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07412275: Microwave Intervention Under Local Anesthesia

Sponsor: Koelis. Phase: NA. Conditions: Localised Prostate Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07369895: Clinical Study of O&D-001 Injection in the Treatment of Relapsed or Refractory Multiple Myeloma

Sponsor: O&D BioTech Group CO., Limited. Phase: PHASE1. Conditions: Relapsed or Refractory Multiple Myeloma

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04773457: Neutrophil Phenotypic Profiling and Surgical Site Infections in Surgical Patients

Sponsor: Boston Children's Hospital. Phase: . Conditions: Surgical Site Infection

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06463457: Comeback From Long coursE Androgen Deprivation Therapy (ADT) With RElugolix and Darolutamide (CLEARED)

Sponsor: Atish Choudhury, MD. Phase: PHASE2. Conditions: Prostate Cancer, Advanced Prostate Cancer, Hormone Sensitive Prostate Cancer

full page →ctgov ↗
›TERMINATEDphase readoutNCT06535477: Fall Risk Assessment With an Innovative Device for Quantifying Gait and Static Balance in Geriatric Consultation

Sponsor: Gérond'if. Phase: NA. Conditions: Risk of Falling in the Elderly

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07347457: Functional Rehabilitation Effects on Exercise-induced Hypoalgesia in Chronic Low Back Pain

Sponsor: Clinique de la Mitterie. Phase: NA. Conditions: Low Back Pain

full page →ctgov ↗
›COMPLETEDphase readoutNCT07495553: Web-Based Filial Therapy In Pediatric Cancer

Sponsor: serap güleç keskin. Phase: NA. Conditions: Pediatric Cancer, Parental Stress, Parenting Anxiety

full page →ctgov ↗
›RECRUITINGphase readoutNCT06075745: Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: PHASE2. Conditions: Liver Transplant

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07471672: Spot Compression Ultrasound Compared to Traditional Breast Ultrasound

Sponsor: Duke University. Phase: NA. Conditions: Breast Mass

full page →ctgov ↗
›RECRUITINGphase readoutNCT06283472: Enhancing Prospective Thinking in Early Recovery (BEAM)

Sponsor: Indiana University. Phase: NA. Conditions: Alcohol Use Disorder

full page →ctgov ↗
›TERMINATEDphase readoutNCT05899595: Effects of a Personalized Physical Training to Reduce Fatigue

Sponsor: Centre Hospitalier Universitaire de Saint Etienne. Phase: NA. Conditions: Fatigue Syndrome, Chronic

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03513939: A Safety, Tolerability and Efficacy Study of Sernova's Cell Pouch™ for Clinical Islet Transplantation

Sponsor: Sernova Biotherapeutics Inc.. Phase: PHASE1. Conditions: Type 1 Diabetes Mellitus

full page →ctgov ↗
›COMPLETEDphase readoutNCT05289739: Exercise Training in Childhood Cancer

Sponsor: Johannes Gutenberg University Mainz. Phase: NA. Conditions: Pediatric Oncology

full page →ctgov ↗
›RECRUITINGphase readoutNCT06339177: Hemophagocytic Lymphohistiocytosis (HLH) Evaluation and Research of Clinical, ImmUnoLogic and TranscriptomE Study

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: . Conditions: Lymphohistiocytosis, Hemophagocytic, Secondary Hemophagocytic Lymphohistiocytosis, Macrophage Activation Syndrome, Hyperinflammatory Syndromes

full page →ctgov ↗
← prev
page 92 of 161
next →